IRCCS Istituto Tumori Giovanni Paolo II

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Paclitaxel, Ramucirumab and Tislelizumab Switch Maintenance in Advanced HER2-negative and PD-L1 TAP Score of 5 or More Advanced Gastroesophageal Adenocarcinoma	gastroesophageal adenocarcinoma	Not yet recruiting	Phase 3	2026-08-18		NCT07763171
Emotional Distress in Patients With Metastatic Breast Cancer in First Line of Therapy	Neoplasms by Site, Skin and Connective Tissue Diseases, breast disorder, breast neoplasm, neoplasm, skin disorder	Recruiting	Not stated	2026-06-17		NCT06994377

Clinical trials